VITA 34 AG

XTRA:V3V Rapport sur les actions

Capitalisation boursière : €78.4m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

VITA 34 Gestion

Gestion contrôle des critères 1/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Jakub Baran

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur général2.4yrs
Propriété du PDGn/a
Durée moyenne d'occupation des postes de directionpas de données
Durée moyenne du mandat des membres du conseil d'administration4.1yrs

Mises à jour récentes de la gestion

VITA 34 AG's (ETR:V3V) CEO Compensation Looks Acceptable To Us And Here's Why

Dec 07
VITA 34 AG's (ETR:V3V) CEO Compensation Looks Acceptable To Us And Here's Why

How Is VITA 34's (ETR:V3V) CEO Compensated?

Dec 18
How Is VITA 34's (ETR:V3V) CEO Compensated?

Recent updates

Why We're Not Concerned About VITA 34 AG's (ETR:V3V) Share Price

Apr 04
Why We're Not Concerned About VITA 34 AG's (ETR:V3V) Share Price

Revenues Tell The Story For VITA 34 AG (ETR:V3V) As Its Stock Soars 26%

Dec 24
Revenues Tell The Story For VITA 34 AG (ETR:V3V) As Its Stock Soars 26%

Is VITA 34 (ETR:V3V) Using Too Much Debt?

Nov 23
Is VITA 34 (ETR:V3V) Using Too Much Debt?

Is VITA 34 (ETR:V3V) Using Debt In A Risky Way?

Jul 15
Is VITA 34 (ETR:V3V) Using Debt In A Risky Way?

Is VITA 34 (ETR:V3V) Using Debt In A Risky Way?

Feb 17
Is VITA 34 (ETR:V3V) Using Debt In A Risky Way?

Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

Apr 08
Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

VITA 34 AG's (ETR:V3V) CEO Compensation Looks Acceptable To Us And Here's Why

Dec 07
VITA 34 AG's (ETR:V3V) CEO Compensation Looks Acceptable To Us And Here's Why

Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

May 12
Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

Earnings Miss: VITA 34 AG Missed EPS By 29% And Analysts Are Revising Their Forecasts

Apr 03
Earnings Miss: VITA 34 AG Missed EPS By 29% And Analysts Are Revising Their Forecasts

VITA 34 AG's (ETR:V3V) Intrinsic Value Is Potentially 56% Above Its Share Price

Mar 25
VITA 34 AG's (ETR:V3V) Intrinsic Value Is Potentially 56% Above Its Share Price

Should You Be Adding VITA 34 (ETR:V3V) To Your Watchlist Today?

Mar 10
Should You Be Adding VITA 34 (ETR:V3V) To Your Watchlist Today?

Here's Why VITA 34 (ETR:V3V) Can Manage Its Debt Responsibly

Feb 22
Here's Why VITA 34 (ETR:V3V) Can Manage Its Debt Responsibly

Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

Feb 05
Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

Can Mixed Financials Have A Negative Impact on VITA 34 AG's 's (ETR:V3V) Current Price Momentum?

Jan 18
Can Mixed Financials Have A Negative Impact on VITA 34 AG's 's (ETR:V3V) Current Price Momentum?

Did You Participate In Any Of VITA 34's (ETR:V3V) Fantastic 201% Return ?

Jan 02
Did You Participate In Any Of VITA 34's (ETR:V3V) Fantastic 201% Return ?

How Is VITA 34's (ETR:V3V) CEO Compensated?

Dec 18
How Is VITA 34's (ETR:V3V) CEO Compensated?

Should You Be Adding VITA 34 (ETR:V3V) To Your Watchlist Today?

Dec 01
Should You Be Adding VITA 34 (ETR:V3V) To Your Watchlist Today?

PDG

Jakub Baran

2.4yrs

Titularisation

Mr. Jakub Julian Baran serves as Chairman of the Management Board and Chief Executive Officer at VITA 34 AG since March 22, 2022. He serves as Member of the Supervisory Board at Betacom S.A. since May 2019...


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Isadore Ances
Member of Scientific & Medical Advisory Boardno datapas de donnéespas de données
A. Bader
Member of Scientific & Medical Advisory Boardno datapas de donnéespas de données
Robert Iannone
Member of Scientific & Medical Advisory Boardno datapas de donnéespas de données
W. Holzgreve
Member of Scientific & Medical Advisory Boardno datapas de donnéespas de données
Carlo Croce
Member of Scientific & Medical Advisory Boardno datapas de donnéespas de données
Jack Goldberg
Member of Scientific & Medical Advisory Boardno datapas de donnéespas de données
E. Wunder
Member of Scientific & Medical Advisory Boardno datapas de donnéespas de données
Ronald Wapner
Member of Scientific & Medical Advisory Boardno datapas de donnéespas de données
Zbigniew Mrowiec
Member of Scientific & Medical Advisory Boardno datapas de donnéespas de données
Florian Schuhbauer
Deputy Chairman of the Supervisory Board4.1yrs€20.00kpas de données
Alexander Granderath
Chairman of Supervisory Board2.7yrspas de donnéespas de données
Frank Kohler
Independent Member of the Supervisory Board7.2yrs€30.00kpas de données

4.1yrs

Durée moyenne de l'emploi

Conseil d'administration expérimenté: Les membres du conseil d'administration de V3V sont considérés comme expérimentés (ancienneté moyenne 4.1 ans).